 HAMILTON, ON and BOSTON , April 26, 2022 PRNewswire -- Fusion Pharmaceuticals Inc. Nasdaq: FUSN, a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present at the 2022 Bloom Burton Co. Healthcare Investor Conference in Toronto, Ontario on Monday, May 2, 2022 at 3:30 p.m. ET. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D. 